117 related articles for article (PubMed ID: 38372107)
21. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
22. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.
Niu Q; Liu Z; Gao J; Wang Q
Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245
[TBL] [Abstract][Full Text] [Related]
23. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.
Wang J; Liu L
J Ovarian Res; 2021 Nov; 14(1):165. PubMed ID: 34798882
[TBL] [Abstract][Full Text] [Related]
24. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
[TBL] [Abstract][Full Text] [Related]
25. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
26. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
Fan L; Lei H; Zhang S; Peng Y; Fu C; Shu G; Yin G
Theranostics; 2020; 10(13):5895-5913. PubMed ID: 32483426
[No Abstract] [Full Text] [Related]
27. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
[TBL] [Abstract][Full Text] [Related]
28. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
29. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.
Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H
BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801
[TBL] [Abstract][Full Text] [Related]
30. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
31. Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.
Zhang L; Chen Y; Li F; Bao L; Liu W
Front Immunol; 2019; 10():867. PubMed ID: 31105696
[TBL] [Abstract][Full Text] [Related]
32. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
33. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract][Full Text] [Related]
34. The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.
Zhang W; Hu Y; Zhang W; Yi K; Xu X; Chen Z
J Immunol Res; 2022; 2022():9385820. PubMed ID: 35692499
[TBL] [Abstract][Full Text] [Related]
35. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
36. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
[TBL] [Abstract][Full Text] [Related]
37. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
38. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
39. Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.
Liu YK; Jia YJ; Liu SH; Shi HJ; Ma J
Histol Histopathol; 2021 May; 36(5):535-545. PubMed ID: 33570156
[TBL] [Abstract][Full Text] [Related]
40. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]